APA (7th ed.) Citation

Kimpel, J., Laer, D. v., Schwaiger, T., Wollmann, G., Hatami, J., Das, K., . . . Bánki, Z. Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Kimpel, Janine, et al. Interleukin-12 Encoded by the Oncolytic Virus VSV-GP Enhances Therapeutic Antitumor Efficacy by Inducing CD8+ T-cell Responses with a Long-lived Effector Cell Phenotype. BMJ Publishing Group.

MLA (9th ed.) Citation

Kimpel, Janine, et al. Interleukin-12 Encoded by the Oncolytic Virus VSV-GP Enhances Therapeutic Antitumor Efficacy by Inducing CD8+ T-cell Responses with a Long-lived Effector Cell Phenotype. BMJ Publishing Group.